| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 04/29/2026 | ±2.9% | +6.5% | under-priced |
| 02/18/2026 | ±5.1% | +3.8% | over-priced |
| 10/29/2025 | ±1.4% | -10.4% | under-priced |
| 07/30/2025 | ±1.2% | -6.3% | under-priced |
| 05/07/2025 | ±2.0% | +4.6% | under-priced |
| 02/26/2025 | ±1.5% | -3.9% | under-priced |
| 10/30/2024 | ±1.6% | +4.5% | under-priced |
| 07/31/2024 | ±1.8% | -8.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.73 | $783M | $234M |
| Q4 FY2025 | — | $779M | $197M |
| Q3 FY2025 | $1.61 | $768M | $226M |
| Q2 FY2025 | $1.81 | $773M | $253M |
VRSK (VRSK) reports imminently, with the next report estimated for 10/26/2026. Across the last 8 reports, options priced an average ±2.2% earnings move while the stock actually moved 6.1% on average — the market has tended to under-price VRSK's earnings risk. Fundamentals into the print: EPS up 4.8% year-over-year, revenue up 3.9%. QuantLogix's live 5-factor engine currently reads VRSK as a buy at 72/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →